Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: A multicentre randomised double-blind study

  • David Chadwick*
  • , J. Baldy-Moulinier
  • , E. Ben-Manachem
  • , R. Beran
  • , A. Bes
  • , L. D. Biermann
  • , J. M. Bird
  • , L. Boon
  • , E. Byrne
  • , E. P. Calandre
  • , E. V. de Seijas
  • , J. A. Tejerina
  • , R. Canger
  • , A. Saltarelli
  • , N. E.F. Cartlidge
  • , R. N. Corston
  • , V. Cosi
  • , C. Dellaportas
  • , J. Duncan
  • , W. Van Paesschen
    • M. Dam, G. Danta, H. Gadot, A. N. Gale, D. Gisselbrecht, M. Gross, W. M. Guldenpfennig, J. Haan, S. J.L. Howell, G. S. Venables, J. Jankovic, R. Kälviäinen, P. Riekkinen, K. Kennedy, G. Kramer, P. H. Kritzinger, J. Manelis, R. Michelucci, C. A. Tassinari, M. Neufeld, B. Pederson, F. Pisani, A. Reches, B. Ried, E. A.C.M. Saunders, E. Somerville, L. Spechio, L. A. Neve, L. Tramacere, H. Stefan, A. Tartara, A. D. Van As, C. A. Van Donsellar, M. Weber, H. G. Wieser, G. Zaccara, G. T. Gomez
*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

164 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: A multicentre randomised double-blind study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science